Skip to main content
Fig. 9 | Journal of Nanobiotechnology

Fig. 9

From: Biodegradable and biocompatible subcutaneous implants consisted of pH-sensitive mebendazole-loaded/folic acid-targeted chitosan nanoparticles for murine triple-negative breast cancer treatment

Fig. 9

Assessment of the CS-FA-MBZ implants biocompatibility according to blood biochemical analyzes and histopathological evaluation of vital organs. a Serum level of BUN, Cr, ALT, and AST of the CS-FA-MBZ implanted mice (n = 5) 30 days after implantation in comparison with the Control, MBZ, and CS-FA groups. There is no statistical difference between the groups. b H&E-stained sections of lungs, kidneys, spleen, and liver of the CS-FA-MBZ implanted mice (n = 5) 30 days after implantation in comparison with the Control, MBZ, and CS-FA groups

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us